Technical tips and recent development of endoscopic ultrasound‐guided choledochoduodenostomy

Abstract Various efforts to improve technical success rates and decrease adverse event rates have also been described in endoscopic ultrasound (EUS)‐guided choledochoduodenostomy (CDS). In particular, lumen‐apposing metal stents (LAMS) may open novel opportunities in EUS‐biliary drainage (BD). To da...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Takeshi Ogura, Takao Itoi
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
EUS
Acceso en línea:https://doaj.org/article/d2f8df9cbc4d44439a9c408a3c8dfe06
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d2f8df9cbc4d44439a9c408a3c8dfe06
record_format dspace
spelling oai:doaj.org-article:d2f8df9cbc4d44439a9c408a3c8dfe062021-11-16T19:20:28ZTechnical tips and recent development of endoscopic ultrasound‐guided choledochoduodenostomy2692-460910.1002/deo2.8https://doaj.org/article/d2f8df9cbc4d44439a9c408a3c8dfe062021-04-01T00:00:00Zhttps://doi.org/10.1002/deo2.8https://doaj.org/toc/2692-4609Abstract Various efforts to improve technical success rates and decrease adverse event rates have also been described in endoscopic ultrasound (EUS)‐guided choledochoduodenostomy (CDS). In particular, lumen‐apposing metal stents (LAMS) may open novel opportunities in EUS‐biliary drainage (BD). To date, various studies have been reported with EUS‐CDS using LAMS, so we should clarify the benefits and limitations of recent EUS‐CDS based on developments in both techniques and devices. In this review, we provide technical tips and describe recent developments in EUS‐CDS, along with a review of the recent literature (between 2015 and 2020). The overall technical success rate is 95.0% (939/988), and the overall clinical success rate is 97.0% (820/845). The most frequent adverse event is cholangitis or cholecystitis (24.5%, 27/110). According to previous review, pneumoperitoneum (28%, 9/34) or peritonitis associated with bile leak (23.5%, 8/34) was most commonly observed. This difference might be based on improvements in dilation devices or the use of covered metal stents. Several randomized controlled trials comparing EUS‐CDS and endoscopic retrograde cholangiopancreatography (ERCP) for malignant biliary obstruction have recently been reported. To summarize, overall technical success rates for ERCP and EUS‐CDS were 92.7% (101/109) and 91.1% (72/79), respectively (p = 0.788). Overall clinical success rates for ERCP and EUS‐CDS were 94.1% (96/102) and 93.6% (72/78), respectively (p = 0.765). Further high‐quality evidence is needed to establish EUS‐CDS as a primary drainage technique.Takeshi OguraTakao ItoiWileyarticleadverse eventsEUSEUS‐CDSEUS‐guided biliary drainagelumen‐apposing metal stentDiseases of the digestive system. GastroenterologyRC799-869ENDEN Open, Vol 1, Iss 1, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic adverse events
EUS
EUS‐CDS
EUS‐guided biliary drainage
lumen‐apposing metal stent
Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle adverse events
EUS
EUS‐CDS
EUS‐guided biliary drainage
lumen‐apposing metal stent
Diseases of the digestive system. Gastroenterology
RC799-869
Takeshi Ogura
Takao Itoi
Technical tips and recent development of endoscopic ultrasound‐guided choledochoduodenostomy
description Abstract Various efforts to improve technical success rates and decrease adverse event rates have also been described in endoscopic ultrasound (EUS)‐guided choledochoduodenostomy (CDS). In particular, lumen‐apposing metal stents (LAMS) may open novel opportunities in EUS‐biliary drainage (BD). To date, various studies have been reported with EUS‐CDS using LAMS, so we should clarify the benefits and limitations of recent EUS‐CDS based on developments in both techniques and devices. In this review, we provide technical tips and describe recent developments in EUS‐CDS, along with a review of the recent literature (between 2015 and 2020). The overall technical success rate is 95.0% (939/988), and the overall clinical success rate is 97.0% (820/845). The most frequent adverse event is cholangitis or cholecystitis (24.5%, 27/110). According to previous review, pneumoperitoneum (28%, 9/34) or peritonitis associated with bile leak (23.5%, 8/34) was most commonly observed. This difference might be based on improvements in dilation devices or the use of covered metal stents. Several randomized controlled trials comparing EUS‐CDS and endoscopic retrograde cholangiopancreatography (ERCP) for malignant biliary obstruction have recently been reported. To summarize, overall technical success rates for ERCP and EUS‐CDS were 92.7% (101/109) and 91.1% (72/79), respectively (p = 0.788). Overall clinical success rates for ERCP and EUS‐CDS were 94.1% (96/102) and 93.6% (72/78), respectively (p = 0.765). Further high‐quality evidence is needed to establish EUS‐CDS as a primary drainage technique.
format article
author Takeshi Ogura
Takao Itoi
author_facet Takeshi Ogura
Takao Itoi
author_sort Takeshi Ogura
title Technical tips and recent development of endoscopic ultrasound‐guided choledochoduodenostomy
title_short Technical tips and recent development of endoscopic ultrasound‐guided choledochoduodenostomy
title_full Technical tips and recent development of endoscopic ultrasound‐guided choledochoduodenostomy
title_fullStr Technical tips and recent development of endoscopic ultrasound‐guided choledochoduodenostomy
title_full_unstemmed Technical tips and recent development of endoscopic ultrasound‐guided choledochoduodenostomy
title_sort technical tips and recent development of endoscopic ultrasound‐guided choledochoduodenostomy
publisher Wiley
publishDate 2021
url https://doaj.org/article/d2f8df9cbc4d44439a9c408a3c8dfe06
work_keys_str_mv AT takeshiogura technicaltipsandrecentdevelopmentofendoscopicultrasoundguidedcholedochoduodenostomy
AT takaoitoi technicaltipsandrecentdevelopmentofendoscopicultrasoundguidedcholedochoduodenostomy
_version_ 1718426134379495424